Farreh Qatanani

ORCID: 0000-0002-1961-0373

Also affiliated with University of Illinois Chicago

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Prophylactic treatment with BX795 blocks activation of AKT and its downstream targets to protect vaginal keratinocytes and vaginal epithelium from HSV-2 infection”.

Prophylactic treatment with BX795 blocks activation of AKT and its downstream targets to protect vaginal keratinocytes and vaginal epithelium from HSV-2 infection

Antiviral Research(2021)10.1016/j.antiviral.2021.105145

N/A

0.345DataRank · unranked

9 citations

Tejabhiram Yadavalli, Sudhanshu Singh, Farreh Qatanani, Deepak Shukla, Krishnaraju Madavaraju

Heparanase 2 Modulation Inhibits HSV-2 Replication by Regulating Heparan Sulfate

Viruses(2024)10.3390/v16121832

N/A

0.104DataRank · unranked

1 citations

Ipsita Volety, Farreh Qatanani, Deepak Shukla, James Hopkins